Getting A Head Start: Medtech VC Aims Earlier Than Ever Before
As the value of medtech deals increases, investors are increasingly looking for earlier opportunities. COVID-19 has added both impetus and new opportunity, with innovators and investors vying to build a position in digital health technologies, such as remote monitoring and digital therapeutics.
You may also be interested in...
2021 Venture Investment Was Bullish – Will 2022 Be The Same?
The VC market during 2021 was frantic, cash rich and oftentimes appeared to be acting on a “buy now, ask questions later” mentality. With COVID headwinds dwindling, and emerging market uncertainties, what will 2022 bring?
Minute Insight: Olympus Corporation Joins VC Race With Its Own Fund
The Japanese company is hoping to access breaking technologies sooner via earlier investment.
‘Investee’ Eye: Quanta CEO’s Perspective Of Seeking And Obtaining $245m Raise
Quanta CEO John Milad outlines the transitional stage where a company begins to seek large-scale funding for the first time, and debates market valuations.